Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Patnaik

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2019
Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001O Hamid, C Robert, A Daud, et al.
Scientific Reports|December 31, 2020
Hydrogel particles improve detection of SARS-CoV-2 RNA from multiple sample typesR A Barclay, I Akhrymuk, A Patnaik, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 28, 2016
First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomasA Patnaik, L J Appleman, A W Tolcher, et al.
Scientific Reports|February 7, 2023
Magnetic hydrogel particles improve nanopore sequencing of SARS-CoV-2 and other respiratory virusesP Andersen, S Barksdale, R A Barclay, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2019
Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001O Hamid, C Robert, A Daud, et al.
Scientific Reports|December 31, 2020
Hydrogel particles improve detection of SARS-CoV-2 RNA from multiple sample typesR A Barclay, I Akhrymuk, A Patnaik, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 28, 2016
First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomasA Patnaik, L J Appleman, A W Tolcher, et al.
Scientific Reports|February 7, 2023
Magnetic hydrogel particles improve nanopore sequencing of SARS-CoV-2 and other respiratory virusesP Andersen, S Barksdale, R A Barclay, et al.
Pageof 4